Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment for resistant hypertension, becoming the first drug in the endothelin receptor antagonist class for that indication.

The Alters is an extraordinary, unwieldy, high-concept fable in which the narrative and managerial elements fight for ...

Copyright © 2025 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...

The Fund seeks to provide investors with investment results that correspond generally to the price and yield of an equity index, the NASDAQ US High Equity Income Index (the “Index”).